A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib

Autor: Ganjoo, K.N. *, Villalobos, V.M., Kamaya, A., Fisher, G.A., Butrynski, J.E., Morgan, J.A., Wagner, A.J., D'Adamo, D., McMillan, A., Demetri, G.D., George, S.
Zdroj: In Annals of Oncology January 2014 25(1):236-240
Databáze: ScienceDirect